AUD 1.07
(0.47%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 45.91 Million AUD | -7.32% |
2022 | 49.54 Million AUD | -11.12% |
2021 | 55.74 Million AUD | 97.14% |
2020 | 28.27 Million AUD | -13.08% |
2019 | 32.52 Million AUD | 38.2% |
2018 | 23.53 Million AUD | 0.68% |
2017 | 23.37 Million AUD | 42.41% |
2016 | 16.41 Million AUD | -0.76% |
2015 | 16.54 Million AUD | 50.9% |
2014 | 10.96 Million AUD | 21.65% |
2013 | 9.01 Million AUD | -58.39% |
2012 | 21.65 Million AUD | 1.71% |
2011 | 21.29 Million AUD | -3.83% |
2010 | 22.14 Million AUD | 12.71% |
2009 | 19.64 Million AUD | 5.73% |
2008 | 18.57 Million AUD | 69.25% |
2007 | 10.97 Million AUD | 0.0% |
2005 | 20.99 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 64.09 Million AUD | 0.0% |
2023 Q4 | 45.91 Million AUD | 0.0% |
2023 Q2 | 49.3 Million AUD | 0.0% |
2023 FY | 45.91 Million AUD | -7.32% |
2022 Q4 | 49.54 Million AUD | 0.0% |
2022 Q2 | 52.81 Million AUD | 0.0% |
2022 FY | 49.54 Million AUD | -11.12% |
2021 Q2 | 54.35 Million AUD | 0.0% |
2021 FY | 55.74 Million AUD | 97.14% |
2021 Q4 | 55.74 Million AUD | 0.0% |
2020 FY | 28.27 Million AUD | -13.08% |
2020 Q4 | 28.27 Million AUD | 0.0% |
2020 Q2 | 28.3 Million AUD | 0.0% |
2019 Q2 | 24.79 Million AUD | 0.0% |
2019 Q4 | 32.52 Million AUD | 0.0% |
2019 FY | 32.52 Million AUD | 38.2% |
2018 FY | 23.53 Million AUD | 0.68% |
2018 Q2 | 22.55 Million AUD | 0.0% |
2018 Q4 | 23.53 Million AUD | 0.0% |
2017 Q2 | 21.89 Million AUD | 0.0% |
2017 FY | 23.37 Million AUD | 42.41% |
2017 Q4 | 23.37 Million AUD | 0.0% |
2016 FY | 16.41 Million AUD | -0.76% |
2016 Q4 | 16.41 Million AUD | 0.0% |
2016 Q2 | 16.37 Million AUD | 0.0% |
2015 FY | 16.54 Million AUD | 50.9% |
2015 Q4 | 16.54 Million AUD | 0.0% |
2015 Q2 | 11.36 Million AUD | 0.0% |
2014 Q4 | 10.96 Million AUD | 0.0% |
2014 Q2 | 7.99 Million AUD | 0.0% |
2014 FY | 10.96 Million AUD | 21.65% |
2013 FY | 9.01 Million AUD | -58.39% |
2013 Q2 | 20.4 Million AUD | 0.0% |
2013 Q4 | 11.89 Million AUD | 0.0% |
2012 FY | 21.65 Million AUD | 1.71% |
2012 Q4 | 21.65 Million AUD | 0.0% |
2011 FY | 21.29 Million AUD | -3.83% |
2011 Q4 | 21.29 Million AUD | 0.0% |
2010 Q4 | 22.14 Million AUD | 0.0% |
2010 FY | 22.14 Million AUD | 12.71% |
2009 FY | 19.64 Million AUD | 5.73% |
2009 Q4 | 19.64 Million AUD | 0.0% |
2008 FY | 18.57 Million AUD | 69.25% |
2008 Q4 | 18.57 Million AUD | 0.0% |
2007 Q4 | 10.97 Million AUD | 0.0% |
2007 FY | 10.97 Million AUD | 0.0% |
2005 FY | 20.99 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 61.743% |
Adherium Limited | 9.88 Million AUD | -364.382% |
Aroa Biosurgery Limited | 101.82 Million AUD | 54.907% |
Atomo Diagnostics Limited | 11.37 Million AUD | -303.499% |
Anteris Technologies Ltd | 45.7 Million AUD | -0.466% |
Control Bionics Limited | 9.02 Million AUD | -408.614% |
CardieX Limited | 12.64 Million AUD | -262.964% |
Compumedics Limited | 40.35 Million AUD | -13.767% |
Cochlear Limited | 2.74 Billion AUD | 98.327% |
CleanSpace Holdings Limited | 26.05 Million AUD | -76.242% |
EMVision Medical Devices Ltd | 23.97 Million AUD | -91.537% |
Nova Eye Medical Limited | 29.88 Million AUD | -53.652% |
HeraMED Limited | 2.95 Million AUD | -1455.31% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | -277.086% |
ImpediMed Limited | 46.98 Million AUD | 2.281% |
InhaleRx Limited | 1.57 Million AUD | -2811.704% |
LBT Innovations Limited | 7.93 Million AUD | -478.921% |
Micro-X Limited | 26.89 Million AUD | -70.716% |
Neurotech International Limited | 12.21 Million AUD | -275.933% |
OncoSil Medical Limited | 6.71 Million AUD | -583.409% |
PolyNovo Limited | 109.16 Million AUD | 57.941% |
Respiri Limited | 6.19 Million AUD | -641.638% |
SomnoMed Limited | 69.8 Million AUD | 34.225% |
Universal Biosensors, Inc. | 30.12 Million AUD | -52.436% |
Uscom Limited | 5.13 Million AUD | -794.207% |
Visioneering Technologies, Inc. | 11.2 Million AUD | -309.751% |